
zzso zzso was used as a single agent in a broad phase II study involving a variety of advanced zzso zzso A total of 115 patients were treated, of whom 93 were zzso The dosage was 75 zzso repeated every 21 days, with a zzso cumulative dose of 550 zzso Nine responses were achieved in a total of 28 patients with breast cancer zzso The response rate was zzso in breast cancer patients receiving zzso as zzso treatment, zzso in patients previously given chemotherapy without zzso and zzso in patients previously given chemotherapy with zzso Some therapeutic activity was also detected in zzso zzso zzso zzso of the zzso zzso lymphoma, melanoma, and skin zzso zzso but the number of patients entered in the study with these various tumors was too limited to allow any statement on efficacy of zzso No treatment schedule with zzso had to be interrupted because of zzso In a total of zzso zzso cycles, only three acute zzso zzso abnormalities were zzso In 16 of 109 zzso patients there was some minor or moderate zzso of one or more of the three major blood cell parameters following zzso therapy, requiring a postponement of the next cycle by less than or equal to 10 zzso 

